Scholarlink

Purpose <p>Whole-body post-therapy SPECT/CT plays an important role in [<sup>177</sup>Lu]Lu-PSMA-617 (LuPSMA) radiopharmaceutical therapy for verifying biodistribution, assessing treatment response, and performing radiation dosimetry. However, conventional dual-head NaI(Tl)-based scanners typically require lengthy scans, which can be resource-intensive and challenging for patient compliance, limiting their routine use in clinical practice. This study explores reducing acquisition duration using dual-energy peaks to increase count statistics and Monte Carlo-based scatter correction (MCS) to maintain image quality and quantitative accuracy under low-count conditions.</p> Methods <p>LuPSMA scans (33 studies from 29 patients) covering mid-thigh to vertex (3 bed positions) were acquired using a dual-head NaI(Tl)-based scanner (Siemens Intevo) with both 208 and 113&#xa0;keV photopeaks and corresponding scatter windows. Full-duration 12&#xa0;min/bed acquisitions were reconstructed using MCS (Hermia SPECT Reconstruction, Hermes) and the scanner’s energy-window-based scatter correction (EWS), where MCS reconstruction at 12&#xa0;min/bed served as the reference standard. Shorter-duration projections (1.5, 3, and 6&#xa0;min/bed) were synthetically generated and reconstructed using MCS. Image quality metrics, including bias, coefficient of variation (CV), contrast ratio (CR), and signal-to-noise ratio (SNR), were evaluated across segmented organs and tumors.</p> Results <p>MCS reconstructions at 1.5–6&#xa0;min/bed showed &lt; 6% bias in mean organ uptake (median ~ 2%) relative to the 12&#xa0;min/bed MCS (reference), significantly lower (<i>p</i> &lt; 0.01) than the bias for 12&#xa0;min/bed EWS (median ~ 3%). For mean tumor uptake, 3–6&#xa0;min/bed MCS showed &lt; 10% bias (median ~ 5%), with no significant difference from 12&#xa0;min/bed EWS (median ~ 6%). CR remained consistent across all reconstructions (median ~ 5). MCS at 12&#xa0;min/bed had slightly better CV, CR, and SNR than EWS at 12&#xa0;min/bed, though differences were not statistically significant. MCS at 6&#xa0;min/bed was not significantly different from either full-duration reconstruction. Visual assessments supported these findings, with MCS benefits over EWS more pronounced at lower count levels.</p> Conclusion <p>These findings indicate that using dual-energy acquisition with MCS, scan times as short as 3–6&#xa0;min/bed on conventional NaI(Tl)-based scanners maintain sufficient image quality for lesion detection, therapy monitoring, and dosimetry. These reductions in scan time could facilitate the routine implementation of post-LuPSMA SPECT/CT in clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fast [177Lu]Lu-PSMA SPECT/CT with dual-energy acquisition and Monte Carlo-based scatter correction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月12日

查看全文
  • Arda Könik,
  • Benjamin Auer,
  • Shir Hazut Krauthammer,
  • Praful Ravi,
  • Thomas S. C. Ng,
  • Heather A. Jacene

摘要

Purpose

Whole-body post-therapy SPECT/CT plays an important role in [177Lu]Lu-PSMA-617 (LuPSMA) radiopharmaceutical therapy for verifying biodistribution, assessing treatment response, and performing radiation dosimetry. However, conventional dual-head NaI(Tl)-based scanners typically require lengthy scans, which can be resource-intensive and challenging for patient compliance, limiting their routine use in clinical practice. This study explores reducing acquisition duration using dual-energy peaks to increase count statistics and Monte Carlo-based scatter correction (MCS) to maintain image quality and quantitative accuracy under low-count conditions.

Methods

LuPSMA scans (33 studies from 29 patients) covering mid-thigh to vertex (3 bed positions) were acquired using a dual-head NaI(Tl)-based scanner (Siemens Intevo) with both 208 and 113 keV photopeaks and corresponding scatter windows. Full-duration 12 min/bed acquisitions were reconstructed using MCS (Hermia SPECT Reconstruction, Hermes) and the scanner’s energy-window-based scatter correction (EWS), where MCS reconstruction at 12 min/bed served as the reference standard. Shorter-duration projections (1.5, 3, and 6 min/bed) were synthetically generated and reconstructed using MCS. Image quality metrics, including bias, coefficient of variation (CV), contrast ratio (CR), and signal-to-noise ratio (SNR), were evaluated across segmented organs and tumors.

Results

MCS reconstructions at 1.5–6 min/bed showed < 6% bias in mean organ uptake (median ~ 2%) relative to the 12 min/bed MCS (reference), significantly lower (p < 0.01) than the bias for 12 min/bed EWS (median ~ 3%). For mean tumor uptake, 3–6 min/bed MCS showed < 10% bias (median ~ 5%), with no significant difference from 12 min/bed EWS (median ~ 6%). CR remained consistent across all reconstructions (median ~ 5). MCS at 12 min/bed had slightly better CV, CR, and SNR than EWS at 12 min/bed, though differences were not statistically significant. MCS at 6 min/bed was not significantly different from either full-duration reconstruction. Visual assessments supported these findings, with MCS benefits over EWS more pronounced at lower count levels.

Conclusion

These findings indicate that using dual-energy acquisition with MCS, scan times as short as 3–6 min/bed on conventional NaI(Tl)-based scanners maintain sufficient image quality for lesion detection, therapy monitoring, and dosimetry. These reductions in scan time could facilitate the routine implementation of post-LuPSMA SPECT/CT in clinical practice.